Organika Health Products Inc. Junior-Dophilus¿ Capsules
Organika Health Products Inc. Junior-Dophilus¿ Capsules, NPN 80020421: natural health product licensed in Canada. Medicinal ingredients: Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus rhamnosus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium infantis Source : HA-116 | 200 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : HA-122 | 600 Millions d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : HA-111 | 600 Millions d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Hypromellose, Stéarate de magnésium, Dioxyde de silicium, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | Not specified | 1 Capsule | 3 Tous les jours |
| Enfants | minimum: 1 year | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Probiotic that forms part of a natural healthy gut flora. Provides live microorganisms that form part of a natural healthy gut flora. Probiotic that contributes to a natural healthy gut flora. Provides live microorganisms that contribute to a natural healthy gut flora. Probiotic to benefit health and/or confer a health benefit. Provides live microorganisms to benefit health and/or to confer a health benefit.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days. This product has come into contact with milk and soy. Do not use this product if you have milk or soy allergy.
- Contra-Indications
Do not use if you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Product record
- Other names
- Organika Professional Line Junior-Dophilus¿ Vegetarian Capsules
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80020421
- Status
- Active licence
- Licence date
- 30 June 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80020421
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Inc. Junior-Dophilus¿ Capsules: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80020421-organika-health-products-inc-junior-dophilus-capsules, updated 30 June 2010.